ArticleScientific reports2026

Sarcopenia modifies the survival benefit of triple therapy versus TACE alone in elderly patients with unresectable hepatocellular carcinoma: A multicenter retrospective cohort study.

Lin Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.